Literature DB >> 25972082

Possible association of proinflammatory cytokines including IL1β and TNFα with enhanced Th17 cell differentiation in patients with Behcet's disease.

Jun Shimizu1, Kenji Takai1, Erika Takada1, Naruyoshi Fujiwara1, Nagisa Arimitsu1, Yuji Ueda1, Sueshige Wakisaka1, Tomoko Suzuki1, Noboru Suzuki2.   

Abstract

We have reported that helper T type 17 (Th17) cells increased in patients with Behcet's disease (BD). It remains obscure how Th17 cells increase in the patients. We here analyzed whether T cells preferentially differentiate into Th17 cells in response to various inflammatory cytokines in patients with BD. Exogenous interleukin (IL)23 sustained the higher Th17 cell frequencies of CD4+CD45RO+ T cells after a 2-day culture in vitro in patients with BD, whereas the T cell subpopulation of normal individuals did not respond to IL23 to sustain/increase Th17 cell frequencies. IL23 receptor positive cell frequencies in freshly isolated BD CD4+CD45RO+ T cells correlated with Th17 cell frequencies assessed by intracellular cytokine staining. After a 2-day culture with IL23, BD CD4+ T cells retained the correlation between IL23 receptor expression level and extent of IL17 secretion (as indicated by Th17 cell frequencies), whereas such correlation was not noted in normal individuals. IL23 signals with its receptor were thus suggested to induce IL17 secretion (Th17 cell frequencies) in a short-time culture in patients with BD. We cultured CD4+CD45RO- T cells for 11 days with various inflammatory cytokines to study which cytokine associated with the enhanced Th17 frequencies in the patients. IL17 production by CD4+CD45RO- T cells of BD patients increased significantly by the supplementation of IL1β and tumor necrosis factor (TNF)α, in addition to IL23, compared with that of normal individuals. These results suggest that proinflammatory cytokines, such as IL1β, TNFα, and IL23, may associate with the expansion of Th17 cells in patients with BD. This study was registered with the University Hospital Medical Information Network-Clinical Trials Registry (UMIN000003806).

Entities:  

Keywords:  Behcet’s disease; IFNγ; IL17; IL23; IL23 receptor; Th17 cells

Mesh:

Substances:

Year:  2015        PMID: 25972082     DOI: 10.1007/s10067-015-2966-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  24 in total

1.  Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci.

Authors:  Nobuhisa Mizuki; Akira Meguro; Masao Ota; Shigeaki Ohno; Tomoko Shiota; Tatsukata Kawagoe; Norihiko Ito; Jiro Kera; Eiichi Okada; Keisuke Yatsu; Yeong-Wook Song; Eun-Bong Lee; Nobuyoshi Kitaichi; Kenichi Namba; Yukihiro Horie; Mitsuhiro Takeno; Sunao Sugita; Manabu Mochizuki; Seiamak Bahram; Yoshiaki Ishigatsubo; Hidetoshi Inoko
Journal:  Nat Genet       Date:  2010-07-11       Impact factor: 38.330

Review 2.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

3.  Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease.

Authors:  Guillaume Geri; Benjamin Terrier; Michelle Rosenzwajg; Bertrand Wechsler; Maxime Touzot; Danielle Seilhean; Tu-Anh Tran; Bahram Bodaghi; Lucile Musset; Vassili Soumelis; David Klatzmann; Patrice Cacoub; David Saadoun
Journal:  J Allergy Clin Immunol       Date:  2011-07-02       Impact factor: 10.793

4.  Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers.

Authors:  Melike Melikoglu; Serpil Uysal; James G Krueger; Gilla Kaplan; Feride Gogus; Hasan Yazici; Stephen Oliver
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

5.  Skewed TGFβ/Smad signalling pathway in T cells in patients with Behçet's disease.

Authors:  J Shimizu; T Izumi; N Arimitsu; N Fujiwara; Y Ueda; S Wakisaka; H Yoshikawa; F Kaneko; T Suzuki; K Takai; N Suzuki
Journal:  Clin Exp Rheumatol       Date:  2012-09-25       Impact factor: 4.473

6.  Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis.

Authors:  Yi Chen; Claire L Langrish; Brent McKenzie; Barbara Joyce-Shaikh; Jason S Stumhofer; Terrill McClanahan; Wendy Blumenschein; Tatyana Churakovsa; Justin Low; Leonard Presta; Christopher A Hunter; Robert A Kastelein; Daniel J Cua
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

7.  Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease.

Authors:  M Ben Ahmed; H Houman; M Miled; K Dellagi; H Louzir
Journal:  Arthritis Rheum       Date:  2004-07

Review 8.  Th17 and non-classic Th1 cells in chronic inflammatory disorders: two sides of the same coin.

Authors:  Lorenzo Cosmi; Francesco Liotta; Enrico Maggi; Sergio Romagnani; Francesco Annunziato
Journal:  Int Arch Allergy Immunol       Date:  2014-07-12       Impact factor: 2.749

9.  Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome.

Authors:  Joshua D Milner; Jason M Brenchley; Arian Laurence; Alexandra F Freeman; Brenna J Hill; Kevin M Elias; Yuka Kanno; Christine Spalding; Houda Z Elloumi; Michelle L Paulson; Joie Davis; Amy Hsu; Ava I Asher; John O'Shea; Steven M Holland; William E Paul; Daniel C Douek
Journal:  Nature       Date:  2008-03-12       Impact factor: 49.962

10.  Expression of Th-17 and RORγt mRNA in Behçet's Disease.

Authors:  Kamel Hamzaoui; Eya Bouali; Imed Ghorbel; Monia Khanfir; Habib Houman; Agnes Hamzaoui
Journal:  Med Sci Monit       Date:  2011-04
View more
  6 in total

1.  Relative abundance of Megamonas hypermegale and Butyrivibrio species decreased in the intestine and its possible association with the T cell aberration by metabolite alteration in patients with Behcet's disease (210 characters).

Authors:  Jun Shimizu; Takao Kubota; Erika Takada; Kenji Takai; Naruyoshi Fujiwara; Nagisa Arimitsu; Yuji Ueda; Sueshige Wakisaka; Tomoko Suzuki; Noboru Suzuki
Journal:  Clin Rheumatol       Date:  2019-01-09       Impact factor: 2.980

2.  [Efficacy and safety of metformin for Behcet's disease and its effect on Treg/Th17 balance: a single-blinded, before-after study].

Authors:  Chen Yong; Luo Dan; Lin Chenhong; Shen Yan; Cai Jianfei; Guan Jianlong
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-02-28

3.  Interplay between circulating nitric oxide and interleukin-17 in elderly outpatients with non-inflammatory conditions.

Authors:  Gleiciane G Avelar; Wilcelly Machado-Silva; Adriane D Henriques; Jeeser A Almeida; Aparecido P Ferreira; Ciro J Brito; Lucy Gomes; Clayton F Moraes; Otávio T Nóbrega
Journal:  Int J Mol Epidemiol Genet       Date:  2018-06-15

4.  Bifidobacteria Abundance-Featured Gut Microbiota Compositional Change in Patients with Behcet's Disease.

Authors:  Jun Shimizu; Takao Kubota; Erika Takada; Kenji Takai; Naruyoshi Fujiwara; Nagisa Arimitsu; Yuji Ueda; Sueshige Wakisaka; Tomoko Suzuki; Noboru Suzuki
Journal:  PLoS One       Date:  2016-04-22       Impact factor: 3.240

5.  Behҫet's Disease, and the Role of TNF-α and TNF-α Blockers.

Authors:  Tim van der Houwen; Jan van Laar
Journal:  Int J Mol Sci       Date:  2020-04-27       Impact factor: 5.923

Review 6.  The Th17 Pathway in Vascular Inflammation: Culprit or Consort?

Authors:  Marie Robert; Pierre Miossec; Arnaud Hot
Journal:  Front Immunol       Date:  2022-04-11       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.